| Title |
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
|
|---|---|
| Published in |
The Lancet, June 2007
|
| DOI | 10.1016/s0140-6736(07)60946-5 |
| Pubmed ID | |
| Authors |
Jorma Paavonen, David Jenkins, F Xavier Bosch, Paulo Naud, Jorge Salmerón, Cosette M Wheeler, Song-Nan Chow, Dan L Apter, Henry C Kitchener, Xavier Castellsague, Newton S de Carvalho, S Rachel Skinner, Diane M Harper, James A Hedrick, Unnop Jaisamrarn, Genara AM Limson, Marc Dionne, Wim Quint, Bart Spiessens, Pascal Peeters, Frank Struyf, Susan L Wieting, Matti O Lehtinen, Gary Dubin, for the HPV PATRICIA study group |
| Abstract |
The aim of this interim analysis of a large, international phase III study was to assess the efficacy of an AS04 adjuvanted L1 virus-like-particle prophylactic candidate vaccine against infection with human papillomavirus (HPV) types 16 and 18 in young women. |
X Demographics
The data shown below were collected from the profiles of 123 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 29 | 24% |
| United States | 3 | 2% |
| United Kingdom | 2 | 2% |
| Korea, Republic of | 1 | <1% |
| Solomon Islands | 1 | <1% |
| France | 1 | <1% |
| Australia | 1 | <1% |
| Korea, Democratic People's Republic of | 1 | <1% |
| Unknown | 84 | 68% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 120 | 98% |
| Scientists | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 461 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 5 | 1% |
| United States | 5 | 1% |
| Spain | 3 | <1% |
| Japan | 3 | <1% |
| Germany | 2 | <1% |
| United Kingdom | 2 | <1% |
| Denmark | 1 | <1% |
| Chile | 1 | <1% |
| Unknown | 439 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 72 | 16% |
| Student > Bachelor | 66 | 14% |
| Student > Master | 63 | 14% |
| Student > Ph. D. Student | 54 | 12% |
| Student > Doctoral Student | 30 | 7% |
| Other | 95 | 21% |
| Unknown | 81 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 155 | 34% |
| Agricultural and Biological Sciences | 65 | 14% |
| Biochemistry, Genetics and Molecular Biology | 34 | 7% |
| Immunology and Microbiology | 21 | 5% |
| Sports and Recreations | 13 | 3% |
| Other | 73 | 16% |
| Unknown | 100 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 136. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#310,891
of 25,768,270 outputs
Outputs from The Lancet
#3,256
of 42,993 outputs
Outputs of similar age
#442
of 83,739 outputs
Outputs of similar age from The Lancet
#5
of 147 outputs
Altmetric has tracked 25,768,270 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,993 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 83,739 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.